SET-UP A FUNDRAISER The greatest gift you can give is hope. If you would like us to set up your own personalized fundraising page to honor a loved one, to support your event, or to commemorate a special occasion like a birthday or anniversary, please fill out the form here and we will
WHO WE ARE The Children's Brain Tumor Project consists of four primary investigators (PI) with expertise in pediatric neuro-oncological clinical and scientific research. Their collective research interests span a vast range of biological fields - including developmental neurobiology, immunomodulation of brain tumors, cancer metastasis, molecular biology of neuro-oncological diseases, and pharmacological engineering. The
Jan. 15, 2020 - Check out the latest news with the Children's Brain Tumor Project
MEET THE FAMILIES The amazing circle of love and support that formed around Elizabeth Minter during her illness made it possible to launch the Children’s Brain Tumor Project (CBTP) — a research program aimed solely at rare and inoperable brain tumors that strike children. It’s a sad fact that major funding sources
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Prasent ac nibh vestibulum, laoreet ipsum.
Nov. 6, 2019 - In this blog post, Jenn Clayton shares her experience running the 2019 NYC Marathon in memory of her son, Joey. She raised more than $12,000 to support the CBTP!
October, 2020 - Dr. Jeffrey Greenfield was recently awarded $1.08 million in support of his precision medicine initiative. The generous gift from the Patrick Bayly Marsano Foundation will enable a tremendous increase in defining individualized cancer therapies for children with rare and inoperable pediatric brain tumors.
October 18, 2019 - The Second Annual “No Laughing Matter” Fundraiser Raises Almost $600,000 for Pediatric Brain Tumor Research
June 15, 2020 - Learn more about the Children's Brain Tumor Project and the impact we are making by reviewing this comprehensive annual report.
June 1, 2019 - A new research study from the CBTP lab entitled “Combined Targeting of PI3K and MEK Effector Pathways via CED for DIPG Therapy,” was published in Neuro-Oncology Advances on May 29, 2019.
